Position in PRGO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,867
-$97 QoQ
Shares Held
276
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#279
of 334 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Smartleaf Asset Management LLC holds $2,809,974 across 43 Drug Manufacturers - Specialty & Generic names. PRGO ranks #29 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,573 | $493,733 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
28,454 | $456,117 | |
| 3 | ZTS |
Zoetis Inc.
|
5,136 | $369,072 | |
| 4 | HLN |
Haleon plc
|
33,747 | $314,859 | |
| 5 | VTRS |
Viatris Inc
|
14,592 | $231,720 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
4,084 | $193,050 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
341 | $184,764 | |
| 8 | ALKS |
Alkermes plc.
|
2,863 | $150,021 |
All Filings in PRGO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,867 | 276 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,964 | 276 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,154 | 514 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $22,648 | 1,017 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,271 | 347 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,412 | 300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,972 | 349 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $12,721 | 485 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,832 | 305 | Shares | Sole | 2024-10-08 | |
| 2024-03-31 | $12,715 | 395 | Shares | Sole | 2024-10-07 | |
| 2023-12-31 | $8,881 | 276 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||